Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea
· Delayed Price · Currency is KRW 3,640.00
-45.00 (-1.22%)
At close: Apr 28, 2026
Korea Arlico Pharm Revenue
In the year 2025, Korea Arlico Pharm had annual revenue of 201.20B KRW with 5.65% growth. Korea Arlico Pharm had revenue of 48.33B in the quarter ending December 31, 2025, a decrease of -7.66%.
Revenue
201.20B
Revenue Growth
+5.65%
P/S Ratio
0.28
Revenue / Employee
1.80B
Employees
112
Market Cap
56.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 201.20B | 10.77B | 5.65% |
| Dec 31, 2024 | 190.44B | 3.28B | 1.75% |
| Dec 31, 2023 | 187.15B | 19.42B | 11.58% |
| Dec 31, 2022 | 167.74B | 27.58B | 19.68% |
| Dec 31, 2021 | 140.16B | 15.35B | 12.30% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RP Bio | 136.22B |
| Kyung Nam Pharm | 56.18B |
| Eagle Veterinary Technology Co.,Ltd | 43.32B |
| Jin Yang Pharmaceutical | 120.69B |
| BL Pharmtech | 6.51B |
| Korean Drug | 62.51B |
| Sinil Pharmaceutical | 80.56B |
| HLscience | 16.71B |